Singapore-based Temasek aims to boost its Indian portfolio with new capital in healthcare, AI, and finance. The firm has already deployed $9 billion in the country over the last three years, viewing India as a high-growth market despite global economic shifts.
Detailed Coverage
Singaporean state investment firm Temasek is preparing to increase its footprint in India, targeting multi-billion dollar investments across high-growth sectors. Ravi Lambah, Head of India and Strategic Initiatives at Temasek International, confirmed the firm has already invested approximately $9 billion in the country over the past three years. This ongoing commitment highlights India's importance in Temasek’s global strategy as a key engine for long-term growth.
Strategic Focus on Healthcare and Finance
Temasek continues to prioritize its long-standing focus on financial services and healthcare. The firm holds significant investments in major domestic institutions including HDFC Bank, ICICI Bank, HDFC Life, and SBI Life. Beyond traditional banking, Temasek has expanded into asset management, insurance, and fintech, with stakes in companies like HDFC AMC, Pine Labs, and PB Fintech. In the healthcare space, Temasek has backed established names such as Manipal Health, Medanta, and Dr Agarwal's. A notable part of this strategy involves supporting portfolio companies in executing mergers and acquisitions, such as Manipal Health's expansion efforts ahead of a potential public listing.
AI and Consumer Market Expansion
Artificial Intelligence has emerged as a central pillar of Temasek’s global strategy, with the firm aiming to allocate 15% of its total portfolio to AI-related assets within the next five years. Regarding India, the firm anticipates that the most significant opportunities lie in the application of AI technologies rather than in the development of foundational models. Additionally, Temasek remains optimistic about India's domestic consumption story. Despite recent reports of softer urban demand, the firm intends to maintain its investment pace through market cycles, including commitments in sectors like quick commerce and food delivery, which it identifies as early-stage businesses with long-term potential.
Portfolio Management and Economic Context
Although India's contribution to Temasek’s global portfolio share recently moved from 8% to 7%, the firm clarified that this change was primarily due to successful exits from holdings like Schneider Electric India and a partial stake reduction in Bharti Airtel. The investment approach remains rooted in a bottom-up analysis of specific companies rather than rigid regional allocation targets. While the firm recognizes external pressures such as currency volatility, global geopolitical tensions, and fluctuations in oil prices, these factors have not deterred its long-term outlook. Investors should track future developments in Temasek’s Indian portfolio, particularly regarding upcoming IPOs of its healthcare assets and the pace of new capital deployment into AI-integrated businesses.